
Johnson & Johnson Ordered to Pay $572 million in Opioid Trial
The fight for justice in the opioid crisis has begun. On Monday, an Oklahoma judge ruled that Johnson & Johnson (NYSE: JNJ) will pay $572 million for playing a part in the state’s opioid crisis.